Yıl: 2017 Cilt: 54 Sayı: 1 Sayfa Aralığı: 11 - 14 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Prevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients

Öz:
Amaç: Multipl skleroz (MS), dünya genelinde prevelansı gittikçe artan bir merkezi sinir sistemi demiyelinizan hastalığıdır. Küçük ölçekli çalışmalar dışında, Türkiye'de MS sıklığı ile ilgili verilerde bir eksiklik vardır. Bu çalışmada Orta Karadeniz Bölgesi'nde MS prevalansı ve hastaların demografik özelliklerinin belirlenmesi amaçlanmıştır Yöntem: Orta Karadeniz bölgesinde yaşayan ve MS tanısı almış hastalarçalışmaya dahil edildi. Çalışma Türkiye'de hastane tabanlı planlandı.Bulgular: 1787 hasta ile görüşüldü ve bunlardan 1584 'ünde tanı doğ-rulandı. Hastalığın ortalama başlangıç yaşı 29,39±7,6 yıl idi. Hastaların1299'u (%81,9) relapsing remitting MS, 74'ü sekonder progresif MS,77'si relapsing progresif MS, 47'si primer progresif MS ve 87'si klinikizole sendrom klinik formundaydı.Sonuç: Orta Karadeniz Bölgesi MS prevalansı yüksek riskli bir coğrafibölge olarak bulunmuştur. Bu çalışma, Türkiye'de MS prevelansı ile ilgilien büyük coğrafi dağılımı kapsayan en kapsamlı epidemiyolojik çalışmadır.
Anahtar Kelime:

Konular: Nörolojik Bilimler Psikiyatri

Türkiye'de Orta Karadeniz Bölgesindeki Multıpl Skleroz Prevelansı ve Hastaların Demografik Özellikleri

Öz:
Introduction: Multiple sclerosis (MS), a demyelinating disease of the central nervous system, is increasing in prevalence worldwide. Other than small-scale studies, there is a scarcity of data on the prevalence of MS in Turkey. The present study aimed to elucidate the prevalence of MS in the Middle Black Sea Region and the demographic characteristics of patients. Methods: Patients living in the Middle Black Sea Region and who were diagnosed with MS were included. The study was designed based hospital of Turkey.Results: A total of 1,787 patients were interviewed, and a diagnosis of MS was confirmed in 1,584. The prevalence of MS was found to be 43.2/100,000 in the Middle Black Sea Region; this was calculated based on the total population and number of patients in the provincesand districts in this region. The mean age at the disease onset was29.39±7.6 years. Among the patients, 1,299 (81.9%) had relapsing-remittingMS, 74 had secondary progressive MS, 77 had relapsing-progressiveMS, 47 had primary progressive MS, and 87 had clinically isolatedsyndrome.Conclusion: The Middle Black Sea Region was found to have a highrisk for the prevalence of MS. This study is the most comprehensiveepidemiologic study having the largest geographical distribution on theprevalence of MS in Turkey.
Anahtar Kelime:

Konular: Nörolojik Bilimler Psikiyatri
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Debouverie M, Pittion-Vouyovitch S, Louis S, Guillemin F, LORSEP Group. Natural history of multiple sclerosis in a population-based cohort. Eur J Neurol 2008; 15:916-921.
  • 2. Kurtzke JF. A reassessment of the distribution of multiple sclerosis. Part one. Acta Neurol Scand 1975; 51:110-136.
  • 3. Kurtzke JF. Epidemiology of multiple sclerosis including special reference to developing countries. Eur J Neurol 1998; 5:5-6.
  • 4. Türk Börü U, Alp R, Sur H, Gül L. Prevalence of multiple sclerosis door-todoor survey in Maltepe, Istanbul, Turkey. Neuroepidemiology 2006; 27:17-21.
  • 5. Börü UT, Taşdemir M, Güler N, Ayık ED, Kumaş A, Yıldırım S, Duman A, Sur H, Kurtzke JF. Prevalence of multiple sclerosis: door-to-door survey in three rural areas of coastal Black Sea regions of Turkey. Neuroepidemiology 2011; 37:231-235.
  • 6. Alp R, Alp Sİ, Plancı Y, Yapıcı Z, Türk Börü Ü. The prevalence of multiple sclerosis in the north caucasus region of Turkey: Door-to-door epidemiological field study. A Arch Neuropsychiatry 2012; 49: 272-275.
  • 7. Koutsouraki E, Costa V, Baloyannis S. Epidemiology of multiple sclerosis in Europe: a review. Int Rev Psychiatry 2010; 22:2-13.
  • 8. Houzen H, Niino M, Hata D, Nakano F, Kikuchi S, Fukazawa T, Sasaki H. Increasing prevalence and incidence of multiple sclerosis in northern Japan. Mult Scler 2008; 14: 887-892.
  • 9. Elhami SR, Mohammad K, Sahraian MA, Eftekhar H. A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study. Neuroepidemiology 2011; 36: 141-147.
  • 10. Bentzen J, Flachs EM, Stenager E, Brønnum-Hansen H, Koch-Henriksen N. Prevalence of multiple sclerosis in Denmark 1950--2005. Mult Scler 2010; 16:520-525.
  • 11. Debouverie M. Gender as a prognostic factor and its impact on the incidence of multiple sclerosis in Lorraine, France. J Neurol Sci 2009; 286:14-7.
  • 12. Midgard R, Riise T, Nyland H. Epidemiologic trends multiple sclerosis in Møre and Romsdal, Norway: a prevalence/incidence study in a stable population. Neurology 1991; 41:887-892.
  • 13. Weinshenker BG, Rice GP, Noseworthy JH, Carriere W, Baskerville J, Ebers GC. The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 1991; 114:1045-1056.
  • 14. Milonas I, Tsounis S, Logothetis I. Epidemiology of multiple sclerosis in northern Greece. Acta Neurol Scand 1990; 81:43-47.
  • 15. Gusev EI, Zavalishin IA, Boiko AN, Khoroshilova NL, Iakovlev AP. Epidemiological characteristics of multiple sclerosis in Russia. Zh Nevrol Psikhiatr Im S S Korsakova 2002; S3-6.
  • 16. Papathanasopoulos P, Gourzoulidou E, Messinis L, Georgiou V, Leotsinidis M. Prevalence and incidence of multiple sclerosis in western Greece: a 23-year survey. Neuroepidemiology 2008; 30:167-173.
  • 17. Milanov I, Topalov N, Kmetski T. Prevalence of multiple sclerosis in Gypsies and Bulgarians. Neuroepidemiology 1999; 18:218-222.
  • 18. Al-Araji A, Mohammed AI. Multiple sclerosis in Iraq: does it have the same features encountered in Western countries? J Neurol Sci 2005; 234:67-71.
  • 19. Milo R, Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev 2010; 9:A387-394.
  • 20. Simpson S Jr, Blizzard L, Otahal P, Van der Mei I, Taylor B. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry 2011; 82:1132-1141.
  • 21. Greer JM, McCombe PA. Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms. J Neuroimmunol 2011; 234:7-18.
  • 22. Carnevale V, Modoni S, Pileri M, Di Giorgio A, Chiodini I, Minisola S. Longitudinal evaluation of vitamin D status in healthy subjects from southern Italy: seasonal and gender differences. Osteoporos Int 2001; 12:1026-1030.
  • 23. Coo H, Aronson KJ. A systematic review of several potential non-genetic risk factors for multiple sclerosis. Neuroepidemiology 2004; 23:1-12.
  • 24. Sellner J, Kraus J, Awad A, Milo R, Hemmer B, Stüve O. The increasing incidence and prevalence of female multiple sclerosis--a critical analysis of potential environmental factors. Autoimmun Rev 2011; 10:495-502.
  • 25. Granieri E. Socio-cultural aspects of multiple sclerosis. In: Ebers G, editor. Environmental Factors in Multiple Sclerosis. 10th MS Forum Modern Management Workshop. Berlin: Schering AG, Educational Service, 1999:6-9.
  • 26. Pehlivan M, Kürtüncü M, Tüzün E, Shugaiv E, Mutlu M, Eraksoy M, Akman-Demir G. The comparison of socio-economic conditions and personal hygiene habits of neuro-Behçet's disease and multiple sclerosis patients. Int J Hyg Environ Health 2011; 214:335-337.
  • 27. Ramagopalan SV, Dyment DA, Herrera BM, Criscuoli M, Yee IM, Sadovnick AD, Ebers GC. Clustering of autoimmune disease in families at high risk for multiple sclerosis? Lancet Neurol 2007; 6:206-207.
  • 28. Al Jumah M, Kojan S, Al Khathaami A, Al Abdulkaream I, Al Blawi M, Jawhary A. Familial multiple sclerosis: does consanguinity have a role? Mult Scler 2011; 17:487-489.
  • 29. Sahraian MA, Khorramnia S, Ebrahim MM, Moinfar Z, Lotfi J, Pakdaman H. Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time. Eur Neurol 2010; 64:331-336.
  • 30. O'Gorman C, Freeman S, Taylor BV, Butzkueven H, Australian and New Zealand M.S. Genetics Consortium (ANZgene), Broadley SA. Familial recurrence risks for multiple sclerosis in Australia. J Neurol Neurosurg Psychiatry 2011; 82:1351-1354.
  • 31. Willer CJ, Dyment DA, Risch NJ, Sadovnick DA, Ebers CG, Canadian Collaborative Study Group. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A 2003; 100:12877-12882.
  • 32. Kantarci O, Siva A, Eraksoy M, Karabudak R, Sütlaş N, Ağaoğlu J, Turan F, Ozmenoğlu M, Toğrul E, Demirkiran M. Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG). Neurology 1998; 51:765-772.
APA AKDEMİR N, TERZİ M, ARSLAN H, ONAR M (2017). Prevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients. , 11 - 14.
Chicago AKDEMİR Neslihan,TERZİ Murat,ARSLAN HATİCE NİLDEN,ONAR Musa Prevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients. (2017): 11 - 14.
MLA AKDEMİR Neslihan,TERZİ Murat,ARSLAN HATİCE NİLDEN,ONAR Musa Prevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients. , 2017, ss.11 - 14.
AMA AKDEMİR N,TERZİ M,ARSLAN H,ONAR M Prevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients. . 2017; 11 - 14.
Vancouver AKDEMİR N,TERZİ M,ARSLAN H,ONAR M Prevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients. . 2017; 11 - 14.
IEEE AKDEMİR N,TERZİ M,ARSLAN H,ONAR M "Prevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients." , ss.11 - 14, 2017.
ISNAD AKDEMİR, Neslihan vd. "Prevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients". (2017), 11-14.
APA AKDEMİR N, TERZİ M, ARSLAN H, ONAR M (2017). Prevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients. Nöropsikiyatri Arşivi, 54(1), 11 - 14.
Chicago AKDEMİR Neslihan,TERZİ Murat,ARSLAN HATİCE NİLDEN,ONAR Musa Prevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients. Nöropsikiyatri Arşivi 54, no.1 (2017): 11 - 14.
MLA AKDEMİR Neslihan,TERZİ Murat,ARSLAN HATİCE NİLDEN,ONAR Musa Prevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients. Nöropsikiyatri Arşivi, vol.54, no.1, 2017, ss.11 - 14.
AMA AKDEMİR N,TERZİ M,ARSLAN H,ONAR M Prevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients. Nöropsikiyatri Arşivi. 2017; 54(1): 11 - 14.
Vancouver AKDEMİR N,TERZİ M,ARSLAN H,ONAR M Prevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients. Nöropsikiyatri Arşivi. 2017; 54(1): 11 - 14.
IEEE AKDEMİR N,TERZİ M,ARSLAN H,ONAR M "Prevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients." Nöropsikiyatri Arşivi, 54, ss.11 - 14, 2017.
ISNAD AKDEMİR, Neslihan vd. "Prevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients". Nöropsikiyatri Arşivi 54/1 (2017), 11-14.